Answers are grounded in this paper and cite their sources.
In this study, we evaluated the effectiveness of Intra-aortic balloon pump (IABP) therapy in improving hemodynamics and peripheral organ function in advanced heart failure (AdHF) patients who were admitted to the Cardiac Intensive Care (CICU) of a tertiary, high-volume, transplant center with impending or established cardiogenic shock.Hundred-four patients were studied their mean age of was 44 ± 12 years, 76 of them (73.08%) were male.All patients underwent IABP therapy.The median time on IABP support for the entire cohort was 13 days (3 -41.25).The survival rate was 87.62% (88 patients).We observed our cohort's significant improvement in the hemodynamics after right heart catheterization with a decrease of the right atrium pressure (p <0.0001), PA pressure (p<0.001), and pulmonary capillary wedge pressure (p<0.001)).There was also a significant decrease in the NT-proBNP levels (p<0.0001), and improvement in renal function (e GFR (p<0.0001), and urea levels (p<0.001).Sixteen patients (15.38%) ended up in CICU on IABP.We found a significant correlation of death with NT-proBNP levels (p< 0.0014), renal function (p< 0.001), and application of renal dialysis (p< 0.0001), intubation (p<0.006), and with the value of 24-hour lactic acid (p<0.0001).IABP was an effective initial intervention for AdHF patients experiencing severe clinical deterioration.It was a first-line method of managing patients as a bridge to decision for further therapies with positive clinical response in improving their hemodynamics and peripheral organ function.
No takes yet. Share an insight, caveat, or question.
Adamopoulos et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: